182 related articles for article (PubMed ID: 4068002)
1. Study on the inhibition of adenosine deaminase.
Montgomery JA; Thomas HJ; Zell AL; Einsphar HM; Bugg CE
J Med Chem; 1985 Nov; 28(11):1751-3. PubMed ID: 4068002
[TBL] [Abstract][Full Text] [Related]
2. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
Agarwal RP
Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
[No Abstract] [Full Text] [Related]
3. Synthesis of isocoformycin, an adenosine deaminase inhibitor of synthetic origin.
Shimazaki M; Kondo S; Maeda K; Ohno M; Umezawa H
J Antibiot (Tokyo); 1979 May; 32(5):537-8. PubMed ID: 528399
[No Abstract] [Full Text] [Related]
4. Studies on inhibition of adenosine deaminase by isocoformycin in vitro and in vivo.
Shimazaki M; Kumada Y; Takeuchi T; Umezawa H; Watanabe K
J Antibiot (Tokyo); 1979 Jun; 32(6):654-8. PubMed ID: 468739
[TBL] [Abstract][Full Text] [Related]
5. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
Smith CM; Belch A; Henderson JF
Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
[No Abstract] [Full Text] [Related]
6. Tight-binding inhibitors--III. A new approach for the determination of competition between tight-binding inhibitors and substrates--inhibition of adenosine deaminase by coformycin.
Cha S
Biochem Pharmacol; 1976 Dec; 25(24):2695-702. PubMed ID: 1008893
[No Abstract] [Full Text] [Related]
7. Effects of hypoxia on the guinea-pig myocardium following inhibition of adenosine deaminase by coformycin.
Szentmiklósi AJ; Németh M; Cseppentö A; Szegi J; Papp JG; Szekeres L
Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):287-94. PubMed ID: 6476984
[TBL] [Abstract][Full Text] [Related]
8. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
[No Abstract] [Full Text] [Related]
9. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
Ratech H; Thorbecke GJ; Hirschhorn R
Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
[No Abstract] [Full Text] [Related]
10. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of the myocardial actions of adenosine in the presence of coformycin, a specific inhibitor of adenosine deaminase.
Szentmiklósi AJ; Németh M; Cseppentö A; Szegi J; Papp JG; Szekeres L
Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):236-52. PubMed ID: 7103613
[TBL] [Abstract][Full Text] [Related]
12. Adenosine and hypoxic vasodilatation.
Dóra E
J Cereb Blood Flow Metab; 1985 Dec; 5(4):621-4. PubMed ID: 3877069
[No Abstract] [Full Text] [Related]
13. Inhibition of PHA and NaI04 mitogenesis by the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2-deoxycoformycin (2-dCF).
Lum CT; Sutherland DE; Najarian JS
Clin Immunol Immunopathol; 1979 Apr; 12(4):453-9. PubMed ID: 222523
[No Abstract] [Full Text] [Related]
14. Adenosine deaminase inhibitors. Synthesis and biological evaluation of (+/-)-3,6,7,8-tetrahydro-3-[(2-hydroxyethoxy)methyl]imidazo[4,5-d] [1,3]diazepin-8-ol and some selected C-5 homologues of pentostatin.
Showalter HD; Putt SR; Borondy PE; Shillis JL
J Med Chem; 1983 Oct; 26(10):1478-82. PubMed ID: 6604819
[TBL] [Abstract][Full Text] [Related]
15. Transition-state stabilization by adenosine deaminase: structural studies of its inhibitory complex with deoxycoformycin.
Frick L; Wolfenden R; Smal E; Baker DC
Biochemistry; 1986 Apr; 25(7):1616-21. PubMed ID: 3486673
[TBL] [Abstract][Full Text] [Related]
16. Hypnotic effects of deoxycorformycin in rats.
Radulovacki M; Virus RM; Djuricic-Nedelson M; Green RD
Brain Res; 1983 Jul; 271(2):392-5. PubMed ID: 6604561
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP
J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
[No Abstract] [Full Text] [Related]
18. Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo.
Plunkett W; Alexander L; Chubb S; Loo TL
Biochem Pharmacol; 1979; 28(2):201-6. PubMed ID: 426835
[No Abstract] [Full Text] [Related]
19. ATP depletion as a consequence of adenosine deaminase inhibition in man.
Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous epimerization of (S)-deoxycoformycin and interaction of (R)-deoxycoformycin, (S)-deoxycoformycin, and 8-ketodeoxycoformycin with adenosine deaminase.
Schramm VL; Baker DC
Biochemistry; 1985 Jan; 24(3):641-6. PubMed ID: 3873254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
